Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The University of Texas Health Science Center, Houston
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
non-treatment seeking cigarette smokers that report smoking atleast 10 cigarettes per day
You may not be if
greater than mild substance use disorder on drugs other than nicotine
a Diagnostic and Statistical Manual of Mental Disorders(DSM)-IV axis I psychiatric disorder or neurological disease or disorder requiring ongoing treatment and/or making study participation unsafe
significant current suicidal or homicidal ideation - medical conditions contraindicating administration of suvorexant (e.g., severe pulmonary disease, severe cardiovascular disease or clinically abnormal EEG, severe liver or kidney disease, seizure disorder, or sleep disorder - particularly narcolepsy)
taking medications known to have significant drug interactions with the study medication(s) (e.g., Monoamine oxidase inhibitors(MAO) inhibitors, anticonvulsants, haloperidol, phenothiazines, anesthetics, and all sedatives)
currently or recently (last 3 months) treated for substance use \[other than nicotine\] or another psychiatric condition
conditions of probation or parole requiring reports of drug use to officers of the court
impending incarceration
pregnant or nursing for female patients
inability to read, write, or speak English \[required for lab tasks and psychometric scales\]
unwillingness to sign a written informed consent form
subjects with alcohol use disorders or report recent problem drinking (5/4 drinks for males/females in \< 2.5 hours or \> 10 alcoholic drinks per week)
any illness,condition, or use of medications which in the opinion of the PI and/or admitting physician would preclude safe and/or successful completion of the study.
Clareo Health | Suvorexant to Reduce Symptoms of Nicotine Use
